NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary technologies to improve the analytical sensitivity of DNA disease biomarkers.
NuProbe takes a multi-platform approach to apply breakthrough technologies in genomics research to enable diseases to be detected, treated, and cured at early stages for better outcomes with lower costs.
NuProbe has sites in Houston, USA, Shanghai, China and Suzhou, China. Our vision is to offer affordable, timely, and accurate disease state information to enable precision medicine and improve patient outcomes.